Dr Priya Srinivas
Scientist G
Rajiv Gandhi Centre for Biotechnology
Kerala
Expertise:
Oncology
13
Publications
9
Projects
106
Scopus Citations
110
CrossRef
26 Years 1 Month Total Experience
Scopus
106
Citations
4
h-index
CrossRef
110
Citations
5
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Indian Association for Cancer Research (for the term 2022-2025
2022Indian Association for Cancer Research (for the term 2019-2022
2019Indian Association for Cancer Research (for the term 2017-2019
WCC-2018
2018
Mahatma Gandhi Medical College and Hospital
National Institutes of Health
2016
USA.
Ministry of Science and Technology
2013
India and the Centre for the Development of Industrial Technology
Mayo Clinic
2009
Rochester
INSA
2007
and from DBT
DST
2006
India. (Not availed). 2004: Recipient of DST Young Scientist Project (Fast Track Scheme)
India. 1995: Recipient of Junior Research Fellowship (UGC
1997
India. 1994: Qualified the Graduate Aptitude test in Engineering (GATE)
Mahatma Gandhi University
1994
Kerala
Community & Membership
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Personal Details
Doctor of Philosophy
Electronics Test & Development Centre
Scientist G
Aug 2000 – Present
Rajiv Gandhi Centre for Biotechnology
Medical and Health Sciences
Scholarly Work
Can BRCA1-mediated DNA damage repair be influenced by Estrogen Receptor-alpha?
OtherhCG and BRCA1 in gestational trophoblastic diseases (PI
CompletedEffects of Cancer Associated Fibroblasts (CAFs) on BRCA1+/- breast cancer cells; Relation to aggressiveness
CompletedSelective gene expression by plumbagin in BRCA1 blocked ovarian cancer cells: An analysis by subtractive hybridization (PI
CompletedEffects of phytoestrogens (emodin & genistein) on BRCA1 blocked ovarian cancer cells (PI
CompletedPotential role of plumbagin as an anticancer agent in brca1 blocked ovarian cancer cells: comparison with standard chemotherapeutic agents (PI
CompletedMolecular evidence for potential use of plumbagin in brca1 blocked/ mutated cancers (I
CompletedStudies on matrix metalloproteinsase (MMP) gene transcription by nitric oxide: mechanism of MMP gene induction in human colon cancer cells (Co-PI
CompletedMechanisms of anticancer activity of emodin/aloe emodin: effects on cell growth
OtherCharacterization and Therapeutic Interventions of Breast Cancer Stem Cells from BRCA1-Defective Breast Cancer PhD Degree awarded on May 5th
in estrogen responsive breast cancer cells PhD Degree awarded in 25th March
the pregnancy hormone mediated immune modulation in BRCA1 defective breast cancers. (thesis Open Defense conducted on 28th October
2022). thesis Open Defense conducted on 19th May
No Data Found
There is currently nothing to display here.
Scholarly Publications
Discovery of potential small molecule inhibitors against β-hCG: an in silico study with in vitro validation
Open Access
Tumor Suppressor miRNA-based Signatures in Triple Negative Breast Cancer: A Study Based on Big Data Analysis of Gene Expression Omnibus (GEO) Datasets and Its Validation
Open AccessDirect DNA binding by BRCA1 on β-hCG promoter and its clinical implications
Open AccessXenoestrogen and Its Interaction with Human Genes and Cellular Proteins: An In-Silico Study
Open AccessEvaluation of genoprotection against malathion induced toxicity by Orthosiphon thymiflorus Sleesen
Open AccessPerspectives on mechanistic implications of ROS inducers for targeting viral infections
Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis
Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy
Showing 1 to 8 of 13 publications